SAFETY OF TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN PATIENTS AGED 6-17 YEARS WITH SYMPTOMATIC ASTHMA

被引：0

作者：

Vogelberg, C. ^{[1
]}

Szefler, S. J. ^{[2
,3
]}

Hamelmann, E. ^{[4
,5
]}

Boner, A. ^{[6
]}

Moroni-Zentgraf, P. ^{[7
]}

Engel, M. ^{[7
]}

El Azzi, G. ^{[7
]}

Finnigan, H. ^{[8
]}

Vandewalker, M. ^{[9
]}

机构：

[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany

[2] Childrens Hosp Colorado, Dept Paediat, Aurora, CO USA

[3] Univ Colorado Denver, Sch Med, Aurora, CO USA

[4] Evangel Krankenhaus Bielefeld, Bochum, Germany

[5] Ruhr Univ, Allergy Ctr, Bochum, Germany

[6] Univ Verona, Dept Paediat, Verona, Italy

[7] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany

[8] Boehringer Ingelheim Ltd, Biostat & Data Sci, Bracknell, Berks, England

[9] Ozarks Inc, Clin Res, Columbia, MO USA

来源：

THORAX | 2016年 / 71卷

关键词：

INHALED CORTICOSTEROIDS;

D O I：

10.1136/thoraxjnl-2016-209333.298

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

P155

引用

页码：A167 / A167

页数：1

共 50 条

[1] SAFETY OF TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN PATIENTS AGED 6-17 YEARS WITH SYMPTOMATIC ASTHMA
不详
THORAX, 2016, 71 : A272 - A272
[2] SAFETY OF TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN PATIENTS AGED 6-17 YEARS WITH SYMPTOMATIC ASTHMA
Moroni-Zentgraf, Petra
Vogelberg, Christian
Szefler, Stanley J.
Hamelmann, Eckard
Boner, Attilio
Engel, Michael
El Azzi, Georges
Finnigan, Helen
Vandewalker, Mark
RESPIROLOGY, 2017, 22 : 106 - 106
[3] Safety of tiotropium Respimat® add-on therapy in patients aged 6-17 years with symptomatic asthma
Vogelberg, Christian
Szefler, Stanley J.
Hamelmann, Eckard
Boner, Attilio
Moroni-Zentgraf, Petra
Engel, Michael
El Azzi, Georges
Finnigan, Helen
Vandewalker, Mark
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[4] Once-daily tiotropium Respimat® add-on therapy improves PEF in participants aged 6-17 years with symptomatic asthma
Hamelmann, Eckard
Vogelberg, Christian
Bernstein, Jonathan A.
Harper, Thomas, III
Moroni-Zentgraf, Petra
Engel, Michael
El Azzi, Georges
Finnigan, Helen
Szefler, Stanley J.
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[5] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IMPROVES PEF IN PARTICIPANTS AGED 6-17 YEARS WITH SYMPTOMATIC ASTHMA
Moroni-Zentgraf, Petra
Hamelmann, Eckard
Vogelberg, Christian
Bernstein, Jonathan A.
Harper, Thomas, III
Engel, Michael
El Azzi, Georges
Finnigan, Helen
Szefler, Stanley J.
RESPIROLOGY, 2017, 22 : 105 - 105
[6] Once-daily Tiotropium Respimat Add-on Therapy Improves Lung Function in Patients Aged 6-17 Years with Severe Symptomatic Asthma.
Hamelmann, E.
Vogelberg, C.
Goldstein, S.
El Azzi, G.
Engel, M.
Sigmund, R.
Szefler, S.
PEDIATRIC PULMONOLOGY, 2017, 52 : S102 - S102
[7] Tiotropium Respimat® add-on therapy in children with symptomatic asthma
Vogelberg, Christian
Moroni-Zentgraf, Petra
Leonaviciute-Klimantaviciene, Migle
Sigmund, Ralf
Hamelmann, Eckard
Engel, Michael
Szefler, Stanley
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[8] EFFICACY OF TIOTROPIUM IN PATIENTS AGED 6-17 YEARS WITH SEVERE SYMPTOMATIC ASTHMA
Moroni-Zentgraf, Petra
Szefler, Stanley J.
Bernstein, Jonathan A.
Murphy, Kevin R.
El Azzi, Georges
Engel, Michael
Sigmund, Ralf
Hamelmann, Eckard
RESPIROLOGY, 2017, 22 : 104 - 104
[9] Efficacy of Tiotropium in Patients Aged 6-17 Years With Severe Symptomatic Asthma
Szefler, Stan
Bernstein, Jonathan
Murphy, Kevin
el Azzi, Georges
Engel, Michael
Moroni-Zentgraf, Petra
Sigmund, Ralf
Hamelmann, Eckard
CHEST, 2016, 150 (04) : 969A - 969A
[10] Tiotropium as an add-on therapy in patients with symptomatic asthma
Chung, Kian Fan
LANCET RESPIRATORY MEDICINE, 2015, 3 (05): : 331 - 333

← 1 2 3 4 5 →